7Baggers
 OVID: Leerink Partners Initiates Coverage with 'Outperform' Rati  GuruFocus Mon, 17 Nov 2025 13:07:07 GMT
 Ovid Therapeutics (OVID) Receives Positive Outlook from Analyst  GuruFocus Mon, 17 Nov 2025 12:07:02 GMT
 Published on: 2025-11-16 07:02:40  newser.com Sun, 16 Nov 2025 13:02:40 GMT
 Published on: 2025-11-16 05:07:57  newser.com Sun, 16 Nov 2025 11:07:57 GMT
 Published on: 2025-11-14 21:11:45  newser.com Sat, 15 Nov 2025 03:11:45 GMT
 Chutes & Ladders—Ovid eyes next chapter with CEO transition  Fierce Biotech Fri, 14 Nov 2025 13:30:00 GMT
 TD Cowen Maintains Ovid Therapeutics(OVID.US) With Buy Rating  富途牛牛 Thu, 13 Nov 2025 20:31:00 GMT
 Ovid Therapeutics (OVID) Reports Q3 Loss, Lags Revenue Estimates  sharewise.com Thu, 13 Nov 2025 05:49:56 GMT
 Ovid Therapeutics Reports Q3 2025 Financial Results  TipRanks Thu, 13 Nov 2025 04:22:36 GMT
 Ovid Therapeutics earnings missed by $0.02, revenue fell short of estimates  Investing.com Nigeria Thu, 13 Nov 2025 00:56:24 GMT
 William Blair Maintains Ovid Therapeutics(OVID.US) With Buy Rating  富途牛牛 Wed, 12 Nov 2025 21:31:00 GMT
 Ovid Therapeutics reports Q3 EPS (17c), consensus (15c)  TipRanks Wed, 12 Nov 2025 15:06:11 GMT
 CEO shuffle at Ovid, Metagenomi  FirstWord Pharma Wed, 12 Nov 2025 14:11:24 GMT
 ovid therapeutics (ovid) reports q3 loss, lags revenue estimates  Yahoo Finance Wed, 12 Nov 2025 13:10:02 GMT
 ovid therapeutics names meg alexander ceo  MarketScreener Wed, 12 Nov 2025 13:04:32 GMT
 Meg Alexander to become Ovid Therapeutics CEO as pipeline advances  Investing.com India Wed, 12 Nov 2025 13:03:08 GMT
 Ovid (OVID) Reports Q3 Revenue Below Expectations  GuruFocus Wed, 12 Nov 2025 12:43:47 GMT
 Ovid Therapeutics Q3 revenue slightly beats expectations  MarketScreener Wed, 12 Nov 2025 12:17:26 GMT
 Ovid Therapeutics Inc. SEC 10-Q Report  TradingView Wed, 12 Nov 2025 12:13:01 GMT
 Ovid Therapeutics Announces Planned Leadership Succession  GlobeNewswire Wed, 12 Nov 2025 12:00:00 GMT
 published on: 2025-11-12 04:00:20  newser.com Wed, 12 Nov 2025 10:00:20 GMT
 published on: 2025-11-11 13:09:19  newser.com Tue, 11 Nov 2025 19:09:19 GMT
 published on: 2025-11-11 02:35:58  newser.com Tue, 11 Nov 2025 08:35:58 GMT
 published on: 2025-11-10 03:52:39  newser.com Mon, 10 Nov 2025 09:52:39 GMT
 Ovid Therapeutics Drives Discovery In Neurological Conditions  Kalkine Media Mon, 10 Nov 2025 08:00:00 GMT
 published on: 2025-11-05 21:39:18  newser.com Thu, 06 Nov 2025 03:39:18 GMT
 ovid therapeutics (ovid) to release earnings on tuesday  MarketBeat Wed, 05 Nov 2025 16:18:06 GMT
 published on: 2025-11-04 05:50:05  newser.com Tue, 04 Nov 2025 11:50:05 GMT
 ovid therapeutics raises $175 million through pipe financing  Finimize Fri, 31 Oct 2025 07:00:00 GMT
 ovid therapeutics raises $175 million through pipe financing  Finimize Thu, 30 Oct 2025 07:00:00 GMT
 short interest in ovid therapeutics (nasdaq:ovid) grows by 463.2%  MarketBeat Wed, 29 Oct 2025 11:03:46 GMT
 ovid therapeutics raises $175 million through pipe financing  Finimize Wed, 29 Oct 2025 07:00:00 GMT
 ovid pre 14a: approvals for series b conversion and warrants  Stock Titan Tue, 28 Oct 2025 10:52:30 GMT
 ovid therapeutics raises $175 million through pipe financing  Finimize Tue, 28 Oct 2025 07:00:00 GMT

Ovid Therapeutics Inc
(NASDAQ:OVID) 

OVID stock logo

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase III clinical trial for the treatment of angelman syndrome in adults; and ...

Founded: 2014
Full Time Employees: 65
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends